MARKET

HNSBF

HNSBF

Hansa Medical AB
EXMKT
2.900
NaN%
Opening 09:30 10/05 EDT
OPEN
--
PREV CLOSE
2.900
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
3.300
52 WEEK LOW
2.900
MARKET CAP
295.11M
P/E (TTM)
-3.5587
1D
5D
1M
3M
1Y
5Y
1D
Hansa Biopharma CEO to Join Industry Panel at Biotech in Europe Forum
TipRanks · 3d ago
Hansa Biopharma Taps Cradle’s AI Platform to Speed Autoimmune Drug Discovery
TipRanks · 4d ago
Hansa Biopharma Adds Commercial and Financial Heavyweights to Board
TipRanks · 09/24 05:33
Hansa Biopharma Adds New Directors and Adopts Long-Term RSU Program at Extraordinary Meeting
TipRanks · 09/22 16:02
Hansa Biopharma Joins Global Expansion Panel at LSX Congress USA
TipRanks · 09/21 15:32
Hansa Biopharma Calls Extraordinary Meeting to Reshape Board and Governance
TipRanks · 08/21 06:02
Hansa Biopharma Prepares for Potential U.S. ADS Listing and Global Share Offering
TipRanks · 08/21 05:32
Hansa Biopharma Marks First Commercial Idefirix Kidney Transplant in Australia
TipRanks · 08/18 06:33
More
About HNSBF
Hansa Biopharma AB, formerly Hansa Medical AB, is a Sweden-based biopharmaceutical company with focus on immunomodulatory enzymes for treatment and prevention of rare and severe autoimmune conditions and transplant rejection. The Company’s operations consist of research and development for drug discovery. The Company conducts several projects, among which primary are IdeS (Immunoglobulin G-degrading enzyme of Streptococcus pyogenes) and HBP-assay (Heparin Binding Protein-assay). IdeS’s goal is to enable transplantation that prevents antibody-mediated rejection. HBP-assay is a diagnostic method that aims to predict severe sepsis in patients with infectious disease symptoms. The Company’s patent portfolio consists of several patent families that geographically cover numerous jurisdictions, including the United States, Europe and Japan.

Webull offers Hansa Biopharma AB stock information, including EXMKT: HNSBF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HNSBF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HNSBF stock methods without spending real money on the virtual paper trading platform.